Joseph Jorizzo to Lupus Erythematosus, Systemic
This is a "connection" page, showing publications Joseph Jorizzo has written about Lupus Erythematosus, Systemic.
Connection Strength
0.287
-
Sugai DY, Gustafson CJ, De Luca JF, Davis SA, Jorizzo JL, O'Rourke KS, Feldman SR. Trends in the outpatient medication management of lupus erythematosus in the United States. J Drugs Dermatol. 2014 May; 13(5):545-52.
Score: 0.114
-
Petri M, Orbai AM, Alarcón GS, Gordon C, Merrill JT, Fortin PR, Bruce IN, Isenberg D, Wallace DJ, Nived O, Sturfelt G, Ramsey-Goldman R, Bae SC, Hanly JG, Sánchez-Guerrero J, Clarke A, Aranow C, Manzi S, Urowitz M, Gladman D, Kalunian K, Costner M, Werth VP, Zoma A, Bernatsky S, Ruiz-Irastorza G, Khamashta MA, Jacobsen S, Buyon JP, Maddison P, Dooley MA, van Vollenhoven RF, Ginzler E, Stoll T, Peschken C, Jorizzo JL, Callen JP, Lim SS, Fessler BJ, Inanc M, Kamen DL, Rahman A, Steinsson K, Franks AG, Sigler L, Hameed S, Fang H, Pham N, Brey R, Weisman MH, McGwin G, Magder LS. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum. 2012 Aug; 64(8):2677-86.
Score: 0.101
-
Housman TS, Jorizzo JL, McCarty MA, Grummer SE, Fleischer AB, Sutej PG. Low-dose thalidomide therapy for refractory cutaneous lesions of lupus erythematosus. Arch Dermatol. 2003 Jan; 139(1):50-4.
Score: 0.052
-
Smith ES, Hallman JR, DeLuca AM, Goldenberg G, Jorizzo JL, Sangueza OP. Dermatomyositis: a clinicopathological study of 40 patients. Am J Dermatopathol. 2009 Feb; 31(1):61-7.
Score: 0.020